PortfoliosLab logoPortfoliosLab logo
ARKG vs. JDOC
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

ARKG vs. JDOC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and Jpmorgan Healthcare Leaders ETF (JDOC). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ARKG vs. JDOC - Yearly Performance Comparison


2026 (YTD)202520242023
ARKG
ARK Genomic Revolution Multi-Sector ETF
-8.80%23.04%-28.24%34.85%
JDOC
Jpmorgan Healthcare Leaders ETF
-3.96%15.36%-1.04%10.71%

Returns By Period

In the year-to-date period, ARKG achieves a -8.80% return, which is significantly lower than JDOC's -3.96% return.


ARKG

1D
6.45%
1M
-11.87%
YTD
-8.80%
6M
-4.86%
1Y
27.26%
3Y*
-4.22%
5Y*
-21.56%
10Y*
4.69%

JDOC

1D
2.32%
1M
-6.11%
YTD
-3.96%
6M
6.94%
1Y
5.14%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ARKG vs. JDOC - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than JDOC's 0.65% expense ratio.


Return for Risk

ARKG vs. JDOC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3636
Overall Rank
ARKG Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 4646
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3535
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3535
Calmar Ratio Rank
ARKG Martin Ratio Rank: 2929
Martin Ratio Rank

JDOC
JDOC Risk / Return Rank: 2121
Overall Rank
JDOC Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
JDOC Sortino Ratio Rank: 2020
Sortino Ratio Rank
JDOC Omega Ratio Rank: 1919
Omega Ratio Rank
JDOC Calmar Ratio Rank: 2424
Calmar Ratio Rank
JDOC Martin Ratio Rank: 2020
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. JDOC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and Jpmorgan Healthcare Leaders ETF (JDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARKGJDOCDifference

Sharpe ratio

Return per unit of total volatility

0.61

0.30

+0.31

Sortino ratio

Return per unit of downside risk

1.19

0.54

+0.65

Omega ratio

Gain probability vs. loss probability

1.13

1.07

+0.07

Calmar ratio

Return relative to maximum drawdown

0.82

0.54

+0.28

Martin ratio

Return relative to average drawdown

2.22

1.24

+0.98

ARKG vs. JDOC - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 0.61, which is higher than the JDOC Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of ARKG and JDOC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ARKGJDOCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.61

0.30

+0.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

0.59

-0.51

Correlation

The correlation between ARKG and JDOC is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

ARKG vs. JDOC - Dividend Comparison

ARKG has not paid dividends to shareholders, while JDOC's dividend yield for the trailing twelve months is around 0.92%.


TTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
JDOC
Jpmorgan Healthcare Leaders ETF
0.92%0.89%5.57%0.15%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

ARKG vs. JDOC - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than JDOC's maximum drawdown of -20.87%. Use the drawdown chart below to compare losses from any high point for ARKG and JDOC.


Loading graphics...

Drawdown Indicators


ARKGJDOCDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-20.87%

-62.72%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-9.68%

-17.83%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-76.36%

-6.96%

-69.40%

Average Drawdown

Average peak-to-trough decline

-35.30%

-7.01%

-28.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.16%

4.61%

+5.55%

Volatility

ARKG vs. JDOC - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 13.28% compared to Jpmorgan Healthcare Leaders ETF (JDOC) at 5.67%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than JDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ARKGJDOCDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.28%

5.67%

+7.61%

Volatility (6M)

Calculated over the trailing 6-month period

31.86%

10.15%

+21.71%

Volatility (1Y)

Calculated over the trailing 1-year period

44.94%

17.04%

+27.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.37%

14.33%

+31.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.94%

14.33%

+26.61%